G Isabel|D M Wright|J L Henry - JoVE Visualize

Showing results (171-180 of 416) with videos related to

Pageof 42

Sort By:

Clinical Pharmacology and Therapeutics|April 1, 1994

Effect of age and gender on tirilazad pharmacokinetics in humansL K Hulst, J C Fleishaker, G R Peters, et al.

Assessment|September 29, 2001

Evading detection on the MMPI-2: does caution produce more realistic patterns of responding?D J Viglione, D M Wright, N T Dizon, et al.

Neuroscience|April 1, 1997

Substance P and enkephalin immunoreactivities in axonal boutons presynaptic to physiologically identified dorsal horn neurons. An ultrastructural multiple-labelling study in the catW Ma, A Ribeiro-da-Silva, Y De Koninck, et al.

Reproductive Toxicology (Elmsford, N.Y.)|January 11, 1992

Methods of monitoring menstrual function in field studies: attitudes of working womenD M Wright, J S Kesner, S M Schrader, et al.

Biomaterials|March 24, 2009

Hydroxyapatite nano and microparticles: correlation of particle properties with cytotoxicity and biostabilityM Motskin, D M Wright, K Muller, et al.

The Journal of Comparative Neurology|December 2, 1996

Quantitative analysis of substance P-immunoreactive boutons on physiologically characterized dorsal horn neurons in the cat lumbar spinal cordW Ma, A Ribeiro-Da-Silva, Y De Koninck, et al.

Neuroscience|March 23, 2000

Upregulation of an opioid-mediated antinociceptive mechanism in transgenic mice over-expressing substance P in the spinal cordA L McLeod, J Ritchie, A C Cuello, et al.

Neuroscience|April 13, 1999

Transgenic mice over-expressing substance P exhibit allodynia and hyperalgesia which are reversed by substance P and N-methyl-D-aspartate receptor antagonistsA L McLeod, J Ritchie, A C Cuello, et al.

Neuroscience|January 30, 2007

Sensory neuron and substance P involvement in symptoms of a zymosan-induced rat model of acute bowel inflammationA M Landau, K Yashpal, C M Cahill, et al.

Quality Assurance (San Diego, Calif.)|January 1, 1997

A procedure for assessing a contract testing facility: one sponsor's perspectiveM M Twitty, S A Martin, J L Henry, et al.

Pageof 42

Showing results (171-180 of 416) with videos related to

Sort By:

Pageof 42

Clinical Pharmacology and Therapeutics|April 1, 1994

Effect of age and gender on tirilazad pharmacokinetics in humansL K Hulst, J C Fleishaker, G R Peters, et al.

Assessment|September 29, 2001

Evading detection on the MMPI-2: does caution produce more realistic patterns of responding?D J Viglione, D M Wright, N T Dizon, et al.

Neuroscience|April 1, 1997

Substance P and enkephalin immunoreactivities in axonal boutons presynaptic to physiologically identified dorsal horn neurons. An ultrastructural multiple-labelling study in the catW Ma, A Ribeiro-da-Silva, Y De Koninck, et al.

Reproductive Toxicology (Elmsford, N.Y.)|January 11, 1992

Methods of monitoring menstrual function in field studies: attitudes of working womenD M Wright, J S Kesner, S M Schrader, et al.

Biomaterials|March 24, 2009

Hydroxyapatite nano and microparticles: correlation of particle properties with cytotoxicity and biostabilityM Motskin, D M Wright, K Muller, et al.

The Journal of Comparative Neurology|December 2, 1996

Quantitative analysis of substance P-immunoreactive boutons on physiologically characterized dorsal horn neurons in the cat lumbar spinal cordW Ma, A Ribeiro-Da-Silva, Y De Koninck, et al.

Neuroscience|March 23, 2000

Upregulation of an opioid-mediated antinociceptive mechanism in transgenic mice over-expressing substance P in the spinal cordA L McLeod, J Ritchie, A C Cuello, et al.

Neuroscience|April 13, 1999

Transgenic mice over-expressing substance P exhibit allodynia and hyperalgesia which are reversed by substance P and N-methyl-D-aspartate receptor antagonistsA L McLeod, J Ritchie, A C Cuello, et al.

Neuroscience|January 30, 2007

Sensory neuron and substance P involvement in symptoms of a zymosan-induced rat model of acute bowel inflammationA M Landau, K Yashpal, C M Cahill, et al.

Quality Assurance (San Diego, Calif.)|January 1, 1997

A procedure for assessing a contract testing facility: one sponsor's perspectiveM M Twitty, S A Martin, J L Henry, et al.

Pageof 42